Document is current
Any future updates will be listed below
-
Authors
Camou, Fabrice
Serratrice, Christine
Pettazzoni, Magali
Nadjar, Yann
Brassier, Anaïs
Bekri, Soumeya
Cador-Rousseau, Bérengère
Dagneaux, Louis
Dalbies, Florence
Froissart, Roseline
Genevaz, Delphine
Guemann, Anne-Sophie
Hivert, Bénédicte
Leguy-Seguin, Vanessa
Marcel, Catherine
Masseau, Agathe
Michaud, Martin
Pers, Yves-Marie
Stirnemann, Jérôme
Vergnaud, Sabrina
Nguyen, Yann https://orcid.org/0000-0002-0866-3824
Caillaud, Catherine
Pichard, Samia
Berger, Marc G.
Belmatoug, Nadia
-
Funding
Funding for this research was provided by:
French National Ministry of Health
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 4 August 2025
First Online: 27 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: As experts in GD, most members of the CETG have links with the pharmaceutical industry (invitations to conferences, interventions as speakers, project grants, etc.). However, none of the members has an exclusive relationship with any one industrial body. No members of the pharmaceutical industry were involved in drafting or reviewing the PNDS.
